X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder

When treating patients with EBV encephalitis, the possibility of XLP should be considered. Once the diagnosis of XLP is made, aggressive treatment such as rituximab, and other immunosuppressive agents are desired for rapid transition to HSCT.

Detalles Bibliográficos
Autores principales: Mukai, Takeo, Waki, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517224/
https://www.ncbi.nlm.nih.gov/pubmed/37744615
http://dx.doi.org/10.1002/ccr3.7949
_version_ 1785109280048807936
author Mukai, Takeo
Waki, Kenji
author_facet Mukai, Takeo
Waki, Kenji
author_sort Mukai, Takeo
collection PubMed
description When treating patients with EBV encephalitis, the possibility of XLP should be considered. Once the diagnosis of XLP is made, aggressive treatment such as rituximab, and other immunosuppressive agents are desired for rapid transition to HSCT.
format Online
Article
Text
id pubmed-10517224
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105172242023-09-24 X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder Mukai, Takeo Waki, Kenji Clin Case Rep Case Images When treating patients with EBV encephalitis, the possibility of XLP should be considered. Once the diagnosis of XLP is made, aggressive treatment such as rituximab, and other immunosuppressive agents are desired for rapid transition to HSCT. John Wiley and Sons Inc. 2023-09-22 /pmc/articles/PMC10517224/ /pubmed/37744615 http://dx.doi.org/10.1002/ccr3.7949 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Images
Mukai, Takeo
Waki, Kenji
X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
title X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
title_full X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
title_fullStr X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
title_full_unstemmed X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
title_short X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
title_sort x‐linked lymphoproliferative syndrome associated with epstein–barr virus encephalitis and lymphoproliferative disorder
topic Case Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517224/
https://www.ncbi.nlm.nih.gov/pubmed/37744615
http://dx.doi.org/10.1002/ccr3.7949
work_keys_str_mv AT mukaitakeo xlinkedlymphoproliferativesyndromeassociatedwithepsteinbarrvirusencephalitisandlymphoproliferativedisorder
AT wakikenji xlinkedlymphoproliferativesyndromeassociatedwithepsteinbarrvirusencephalitisandlymphoproliferativedisorder

Ejemplares similares